TGTX Reports $205M Q1 Revenue, $195M BRIUMVI Sales, Raises 2026 Guidance to $925M
TG Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $37.41
-5.9% in 7d after detection
Post-detection moves
1h
—
1d
+2.5%
3d
+2.8%
7d
-5.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS